Teva Pharmaceutical Industries (TEVA) News Today $20.88 +4.37 (+26.47%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn'sDecember 17 at 2:25 PM | investopedia.comTeva Pharmaceutical Industries Target of Unusually Large Options Trading (NYSE:TEVA)Teva Pharmaceutical Industries Limited (NYSE:TEVA - Get Free Report) saw some unusual options trading on Tuesday. Stock investors bought 140,688 call options on the company. This is an increase of 504% compared to the average volume of 23,306 call options.December 17 at 1:27 PM | marketbeat.comTeva Pharmaceutical Industries (NYSE:TEVA) Hits New 52-Week High - Time to Buy?Teva Pharmaceutical Industries (NYSE:TEVA) Hits New 52-Week High - Still a Buy?December 17 at 12:11 PM | marketbeat.comTeva Stock Soars on Early Bowel Disease Drug DataDecember 17 at 11:47 AM | msn.comWhy Are Teva And Sanofi Stocks Trading Higher On Tuesday?December 17 at 9:16 AM | benzinga.comTeva, Sanofi say drug to treat IBD met primary targetsDecember 17 at 7:35 AM | reuters.comTeva and Sanofi Announce Duvakitug (Anti-TL1A) Positive Phase 2b Results Demonstrating Best-in-Class Potential in Ulcerative Colitis and Crohn's DiseaseDecember 17 at 7:30 AM | globenewswire.comGeode Capital Management LLC Buys 291,124 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Geode Capital Management LLC lifted its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 3.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 8,792,011 shares of the company's stock after purchasing an additional 291,124 shDecember 17 at 4:15 AM | marketbeat.comLord Abbett & CO. LLC Sells 188,753 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Lord Abbett & CO. LLC trimmed its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 11.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,444,247 sharDecember 16 at 5:39 AM | marketbeat.comPublic Employees Retirement System of Ohio Makes New Investment in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Public Employees Retirement System of Ohio purchased a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 207,085 shares of the company's stock, valDecember 16 at 4:22 AM | marketbeat.comXTX Topco Ltd Sells 38,976 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)XTX Topco Ltd reduced its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 58.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,092 shares of the company'sDecember 14 at 4:26 AM | marketbeat.comHighTower Advisors LLC Buys 122,154 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)HighTower Advisors LLC grew its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 461.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 148,605 shares of the company's stock after purchasing an additionDecember 14 at 3:46 AM | marketbeat.comTCW Group Inc. Makes New $1.29 Million Investment in Teva Pharmaceutical Industries Limited (NYSE:TEVA)TCW Group Inc. purchased a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the third quarter, according to its most recent filing with the SEC. The firm purchased 71,390 shares of the company's stock, valued at approximately $1,286,000. Other large investors havDecember 13, 2024 | marketbeat.comTeva announces new patient access program with Direct ReliefDecember 11, 2024 | markets.businessinsider.comTeva Announces New Patient Access Program with Direct Relief to Provide Access to Inhalers for Uninsured PatientsDecember 11, 2024 | markets.businessinsider.comTeva Pharmaceutical Industries Ltd (TEVA) Launches Inhaler Donation Program for Uninsured PatientsDecember 11, 2024 | gurufocus.comState Street Corp Purchases 1,778,268 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)State Street Corp raised its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 10.0% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 19,500,683 shares of the company's stock after acquiring an additional 1,778,268 shares durinDecember 10, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Purchased by Two Sigma Advisers LPTwo Sigma Advisers LP grew its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 15.3% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,034,500December 9, 2024 | marketbeat.comDorsey Wright & Associates Purchases Shares of 168,862 Teva Pharmaceutical Industries Limited (NYSE:TEVA)Dorsey Wright & Associates acquired a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 168,862 shares of the company's stock, valuedDecember 8, 2024 | marketbeat.comPoint72 Asset Management L.P. Sells 801,505 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Point72 Asset Management L.P. lowered its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 60.8% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 517,712 shares of the company's stock after selling 801,505 shares duriDecember 8, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Has $16.20 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Charles Schwab Investment Management Inc. raised its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 24.7% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 899,175 shares of the companyDecember 8, 2024 | marketbeat.comZacks Research Has Optimistic Outlook of TEVA Q1 EarningsDecember 8, 2024 | americanbankingnews.comWhat is Zacks Research's Forecast for TEVA FY2026 Earnings?December 7, 2024 | americanbankingnews.comZacks Research Has Positive Forecast for TEVA Q1 EarningsTeva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Equities researchers at Zacks Research upped their Q1 2026 earnings estimates for Teva Pharmaceutical Industries in a report issued on Tuesday, December 3rd. Zacks Research analyst R. Department now forecasts that the company willDecember 6, 2024 | marketbeat.comQuadrature Capital Ltd Trims Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Quadrature Capital Ltd reduced its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 59.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 168,023 shares of the comDecember 6, 2024 | marketbeat.comTeva to divest Teva-Takeda business venture in Japan to JKIDecember 6, 2024 | msn.comTeva Pharmaceutical (TEVA) Gets a Buy from Piper SandlerDecember 5, 2024 | markets.businessinsider.comPharma firm Teva to divest its business venture in JapanDecember 5, 2024 | reuters.comTeva Announces Agreement to Divest Teva-Takeda, its Business Venture in JapanDecember 5, 2024 | globenewswire.comTeva Pharmaceutical Industries Limited (TEVA) Presents at 7th Annual Evercore ISI HealthCONx Healthcare Conference Call TranscriptDecember 5, 2024 | seekingalpha.comTeva Pharmaceutical Industries Limited (TEVA) 7th Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)December 5, 2024 | seekingalpha.comJanus Henderson Group PLC Acquires 4,732,374 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Janus Henderson Group PLC raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 7,945.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,791,937 shares of theDecember 5, 2024 | marketbeat.comParkman Healthcare Partners LLC Cuts Stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Parkman Healthcare Partners LLC lessened its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 19.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 285,294 shares of the cDecember 4, 2024 | marketbeat.comParsifal Capital Management LP Has $112.32 Million Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Parsifal Capital Management LP decreased its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 6.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,232,971 shares of the company's stock afterDecember 4, 2024 | marketbeat.comTeva Pharmaceutical Industries Limited (NYSE:TEVA) Shares Bought by Maple Rock Capital Partners Inc.Maple Rock Capital Partners Inc. increased its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 1.0% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional inveDecember 4, 2024 | marketbeat.comTownsquare Capital LLC Buys Shares of 39,350 Teva Pharmaceutical Industries Limited (NYSE:TEVA)Townsquare Capital LLC acquired a new stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 39,350 shaDecember 4, 2024 | marketbeat.comTeva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE TrialDecember 4, 2024 | globenewswire.comHighVista Strategies LLC Lowers Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)HighVista Strategies LLC lessened its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 37.7% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 85,100 shares of the company's stock after selDecember 3, 2024 | marketbeat.comHolocene Advisors LP Has $39.86 Million Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Holocene Advisors LP trimmed its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 51.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,212,083 shares of the cDecember 3, 2024 | marketbeat.comCinctive Capital Management LP Purchases 71,164 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Cinctive Capital Management LP grew its holdings in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 43.8% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 233,495 shares of the company's stock aDecember 3, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 2,376,668 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 237.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,377,517 shares of thDecember 3, 2024 | marketbeat.com142,351 Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Acquired by Fred Alger Management LLCFred Alger Management LLC acquired a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 142,351 shares of the comDecember 2, 2024 | marketbeat.comWhat is Zacks Research's Forecast for TEVA Q1 Earnings?Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) - Equities researchers at Zacks Research boosted their Q1 2025 earnings per share (EPS) estimates for Teva Pharmaceutical Industries in a research note issued on Wednesday, November 27th. Zacks Research analyst R. Department now antDecember 2, 2024 | marketbeat.comBellevue Group AG Reduces Stock Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Bellevue Group AG decreased its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 54.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 70,821 shares of the company's stock after selling 83,9December 1, 2024 | marketbeat.comBNP Paribas Financial Markets Sells 548,003 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)BNP Paribas Financial Markets decreased its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 31.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,168,771 shares of the company's stock after selling 5December 1, 2024 | marketbeat.comGoldentree Asset Management LP Sells 180,657 Shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA)Goldentree Asset Management LP lowered its stake in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 7.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,304,993 shares of the company's stockNovember 29, 2024 | marketbeat.com1,349,274 Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA) Purchased by Sio Capital Management LLCSio Capital Management LLC acquired a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 1,349,274 shares of thNovember 29, 2024 | marketbeat.comVinva Investment Management Ltd Raises Stock Holdings in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Vinva Investment Management Ltd raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 964.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 217,720 shares of the compNovember 29, 2024 | marketbeat.comPublic Sector Pension Investment Board Grows Position in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Public Sector Pension Investment Board raised its position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) by 23.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 580,967November 29, 2024 | marketbeat.comBlueshift Asset Management LLC Buys New Shares in Teva Pharmaceutical Industries Limited (NYSE:TEVA)Blueshift Asset Management LLC bought a new position in shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 41,086 shares of the cNovember 28, 2024 | marketbeat.com Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover TEVA Media Mentions By Week TEVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TEVA News Sentiment▼0.760.80▲Average Medical News Sentiment TEVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TEVA Articles This Week▼148▲TEVA Articles Average Week Get Teva Pharmaceutical Industries News Delivered to You Automatically Sign up to receive the latest news and ratings for TEVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News TAK News BNTX News BGNE News MRNA News VTRS News SMMT News GMAB News RDY News SRPT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TEVA) was last updated on 12/17/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teva Pharmaceutical Industries Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Teva Pharmaceutical Industries With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TEVA Stock Alerts